Zymo Research Corporation, The Epigenetics Company, announces the launch of their services for genetic, epigenetic, and expression analysis.  Zymo Research has developed products and technologies for epigenetics research for over a decade, and two years ago introduced unique methods for genome-wide analysis of DNA methylation.  Since then, Zymo Research has continued to expand their epigenetic analysis capabilities and is now the most established and complete provider of epigenetic services.  Services are available for investigating DNA methylation (5-mC) and hydroxymethylation (5-hmC), as well as targeted DNA methylation analysis of single or multiple genetic loci.  Multiple service options are available to the researcher; each offering varying degrees of genome coverage, so customers can choose the analysis best suited for their needs.  Zymo Research’s epigenetic services make genome-wide analyses affordable for nearly every budget.  No experience with sequencing or bioinformatics technologies is required – simply submit the samples and receive high quality, easy-to-interpret publication-ready data and figures.

There are many unique benefits to using the services offered by Zymo Research, including: the most highly-cited chemistries for bisulfite treatment of DNA for 5-mC analysis, novel library prep workflows for ultra-low DNA inputs, and custom-designed bioinformatics pipelines to ensure seamless data handling, analysis, and delivery.  Additionally, the scientists at Zymo Research have recently developed a novel technique to determine DNA hydroxymethylation levels on a genome-wide scale called Reduced Representation Hydroxymethylation Profiling (RRHP).  RRHP, a service offered exclusively by Zymo Research, is the only method available for reliable single base-pair resolution and strand-specific profiling of 5-hmC modifications in DNA.  Additional services are also available for genetic, epigenetic, and expression analysis, including 5-hmC CapSeq, ChIP-Seq, nucleosome position mapping, RNA-Seq, targeted DNA sequencing, large and small genome sequencing, mitochondrial DNA sequencing, and analysis of DNA modifications by mass spectrometry.  These services can be combined and customized to meet the needs of the researcher depending on the requirements of any particular study.

According to Dr. Marc Van Eden, V.P. of Business Development at Zymo Research, “High throughput Next-Gen sequencing is no longer only reserved for those labs with seemingly unlimited resources.  Now, with the service platforms and bioinformatics technologies from Zymo Research, every laboratory will have access to genome-wide genetic and epigenetic analysis.  This will mark the beginning of a new era in epi-biomarker discovery and validation that will aid in the diagnostics and prognostics of human diseases, and facilitate personalized medicine and companion diagnostics to optimize the efficiency of individualized drug treatment.  Also, we may begin to ask how things like the environment and our diet affect who we are and who we will likely become.”  Dr. Van Eden continues, “The bioinformatics experts at Zymo Research take care of the number crunching and bioinformatics analysis so the customer doesn’t have to.  In addition to sending customers raw data, we also send results in easy-to-digest customizable reports.  Now genome-wide analysis and bioinformatics couldn’t be easier.”

For more information about the epigenetic services, or to inquire, please click here or contact us at services@zymoresearch.com.

“Frost & Sullivan proudly recognizes Zymo Research as the recipient of the 2010 North American Product Quality Leadership Award for Epigenetics. Zymo Research, a private company based in Orange, California, provides top quality products for nucleic acid purification and analysis, and the burgeoning field of epigenetics. Within these focuses, Zymo Research successfully competes with the largest of life sciences companies by constantly innovating and never compromising on quality. The company has fostered a stellar reputation amongst the research community for delivering the highest quality products that are easy to use and perform reliably. For its commitment to product quality and enabling more effective and precise research, Zymo Research is the ideal recipient of the Frost & Sullivan Product Quality Leadership Award.”

“All Product Quality Leaders share a strategy of continually updating products based on market and customer needs. While Zymo’s original EZ DNA Methylation™ kit remains one of the best-selling products on the market, the company has developed multiple updates to the original to improve features and cater to customer demands. Zymo launched the EZ DNA Methylation-Gold™ Kit to improve on processing speed, decreasing reaction time to less than three hours by consolidating steps. The EZ DNA Methylation-Direct™ Kit allows customers to perform conversion directly from cells, tissue, or blood, rather than requiring purified DNA as the input material. The EZ DNA Methylation-Startup™ Kit caters to the first-time user, providing an easy-to-use complete system for bisulfite treatment with controls and PCR amplification. Uniquely, Zymo offers the original, Gold™, and Direct™ kits in high-throughput (96-well) shallow-well or deep-well formats as many laboratories lack the instrumentation to handle deep-well formats. While other vendors only offer single column format conversion kits, by supplying a range of kits with various features, Zymo satisfies the specific needs and applications of various types of DNA methylation end-users. This obsession with product improvement has allowed Zymo to undoubtedly remain atop the market in both quality perception and market share.” Frost & Sullivan, http://www.frost.com.

About Zymo Research
Zymo Research, a private company based in Orange, California, and founded in 1994, has been proudly serving the scientific community by providing proven, trusted, and state-of-the-art DNA and RNA research technologies at affordable prices. The company’s philosophy is to provide the highest quality products in the industry while ensuring they are both simple to use and robust in their performance. Although historically recognized for its innovative DNA and RNA purification technologies, Zymo Research has recently received much attention for its rapidly expanding epigenetics portfolio of products. Branding itself “The Epigenetics Company”, it is Zymo Research’s objective to develop and provide the most comprehensive set of research tools for DNA methylation analysis and epigenetics research available today.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages almost 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.